With box warnings

Without box warnings

Branded

Generic

3 results

cinacalcet
(CINACALCET)
Cipla USA Inc.
Usage: Cinacalcet tablets are indicated for treating secondary hyperparathyroidism in adults with chronic kidney disease on dialysis, hypercalcemia in patients with parathyroid carcinoma, and hypercalcemia in adults with primary hyperparathyroidism when surgery is not an option.
parsabiv
(etelcalcetide)
Amgen Inc
Usage: PARSABIV is indicated for treating secondary hyperparathyroidism in adult patients with chronic kidney disease on hemodialysis. It is not recommended for patients with parathyroid carcinoma, primary hyperparathyroidism, or those with chronic kidney disease not on hemodialysis.
sensipar
(cinacalcet hydrochloride)
Amgen Inc
Usage: Sensipar is indicated for treating secondary hyperparathyroidism in adults with chronic kidney disease on dialysis, hypercalcemia in adults with parathyroid carcinoma, and hypercalcemia in adults with primary hyperparathyroidism who cannot undergo parathyroidectomy. It is not recommended for patients with CKD not on dialysis.

Calcium-sensing Receptor Agonist class drugs

cinacalcet